myLiquitab Closes Funding Round

/, News/myLiquitab Closes Funding Round

myLiquitab Closes Funding Round

myLiquitab is pleased to advise it has closed an equity funding round. The proceeds will be used to manufacture production tooling, procure the materials and components and pay for labour for the first batch of ‘beta’ production myLiquitab units, and for working capital.

mLiquitab is targeting a beta release of units in mid-2016 for user testing and to finalise regulatory approvals. Following the completion of this development phase, myLiquitab is targeting a full product release in the latter half of 2016.

2020-04-16T11:05:04+10:00 March 22nd, 2016|Latest News, News|


  • This field is for validation purposes and should be left unchanged.